Thursday, 09 December 2021 10:41

Strong finish for Fonterra despite Covid - McBride

Written by  Sudesh Kissun
Fonterra chairman Peter McBride Fonterra chairman Peter McBride

Fonterra chairman Peter McBride says the co-operative ended the 2021 financial year in a strong position on several fronts – financial results, strategy implementation and relationship with farmer owners.

Speaking at the co-op’s annual general meeting in Invercargill today, McBride noted that despite all of the disruption at home and in global markets, Fonterra performed well.

“This demonstrates the value of a New Zealand owned co-operative of scale,” he says.

“Fonterra’s scale gives us a level of optionality that is unique in New Zealand dairy.

“It enables us to manage risk and uncertainty on behalf of our kiwi farming families.

“We have benefited greatly from our ability to move your milk between the markets, categories and products that deliver the most value.”

The AGM is being held in-person and online because of Covid travel restrictions in Auckland.

Fonterra’s management team, including chief executive Miles Hurrell, are taking part virtually. Fonterra’s Auckland and Australia based directors are also attending virtually.

McBride noted that for many Fonterra team members, 2021 has been incredibly tough.

“Many of our international team are working away from home, or in densely populated cities where COVID is rife.

“I’d like to use this opportunity to say a thank you to all of our international team on behalf of us farmers.”

He says the hard work and commitment of Fonterra people was reflected in its key 2021 financial results:

  • A final farmgate Milk Price of $7.54, which exceeded opening forecast for the year.
  • Net debt is down $872 million this year to be $3.8 billion, bringing gearing ratio down to just under 36%.
  • Our Total Group normalised EBIT – which reflects the underlying performance of the business – was up 8% to $952 million.
  • Normalised earnings per share was 34 cents, leading to total dividend payments of 20 cents for the year.

More like this

Featured

Call to fast-track animal medicines approval

With an amendment to the Medicines Act proposing human medicines could be approved in 30 days if the product has approval from two recognised overseas jurisdictions, there’s a call for a similar approach where possible to be applied to some animal medicines.

National

Machinery & Products

Farmer-led group buys Novag

While the name and technology remain unchanged and new machines will continue to carry the Novag name, all the assets,…

Buhler name to go

Shareholders at a special meeting have approved a proposed deal that will see Buhler Industries, the publicly traded Versatile and…

» Latest Print Issues Online

The Hound

Inconvenient truth

OPINION: You would've missed this one if you rely on mainstream media for your news, but your old mate reckons…

Keep it real

OPINION: With the Government applying some fiscal discipline to scientific research funding, this mutt thinks it might be timely to…

» Connect with Rural News

» eNewsletter

Subscribe to our weekly newsletter